Management has identified that reasonably possible changes in certain key assumptions including the likelihood of achieving
successful trial results, obtaining regulatory approval, the projected market share of the therapeutic area and expected pricing for launched products may cause the calculated fair value of the above contingent consideration to vary materially in future years.